EMA Withdrawn: Olanzapine Apotex (olanzapine) — Apotex Europe BV

View source ↗

Summary

The EMA has withdrawn Olanzapine Apotex, an olanzapine product from Apotex Europe BV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Olanzapine Apotex (olanzapine)

Snippet

Status: Withdrawn. Therapeutic area: Schizophrenia;Bipolar Disorder. MAH: Apotex Europe BV. Decision date: 08/03/2023